speb/financial-data huggingface dataset:
CMG.TO balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 132871000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 132871000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 54775000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 54775000.00
CMG.TO income_statement (annual, 2026-03-31) — Total Operating Income As Reported: 27045000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 9352000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Total Tax Payable: 2280000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 2280000.00
CMG.TO income_statement (annual, 2026-03-31) — Total Unusual Items: -1783000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: -725000.00
CMG.TO income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -1783000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -725000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Working Capital: 235000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 235000.00
CMGS.TO cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
CMGS.TO income_statement (annual, 2021-12-31) — Other Operating Expenses: 21264000.00
CMGS.TO balance_sheet (annual, 2021-12-31) — Preferred Stock: 0.00
CMGS.TO cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
CMGS.TO balance_sheet (annual, 2021-12-31) — Treasury Shares Number: 452600000.00
CMGS.TO balance_sheet (annual, 2021-12-31) — Treasury Stock: 3356102000.00
CMGS.TO income_statement (annual, 2022-12-31) — +Operating Expense: 851017000.00
CMGS.TO income_statement (annual, 2022-12-31) — +Total Revenue: 8634652000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 184566000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 106880000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1734587000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1829304000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 20738000.00
CMGS.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 4935587841.00
CMGS.TO income_statement (annual, 2022-12-31) — Basic EPS: 0.18
CMGS.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 846230000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -479164000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 3731410000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 373000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 384000000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 899136000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -929404000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -830032000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 1323179000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Change In Account Payable: 18208000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -18100000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Change In Inventory: -3011000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 233927000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -203333000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 79636000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Change In Payable: 18208000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 108000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -14660000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Change In Receivables: -14026000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: 78641000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -14026000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -436257000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Common Stock: 373000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 2368023000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Common Stock Payments: -830140000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Construction In Progress: 123453000.00
CMGS.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 6572533000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 282428000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Current Assets: 1175837000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 236248000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 236248000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 183071000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 183071000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 921880000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Current Provisions: 15227000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Deferred Income Tax: -43195000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Deferred Tax: -43195000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 286826000.00
CMGS.TO income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 286826000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 286826000.00
CMGS.TO income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 286826000.00
CMGS.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 4972980000.00
CMGS.TO income_statement (annual, 2022-12-31) — Diluted EPS: 0.18
CMGS.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 899101000.00
CMGS.TO income_statement (annual, 2022-12-31) — EBIT: 1211102000.00
CMGS.TO income_statement (annual, 2022-12-31) — EBITDA: 1497928000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -1007000.00
CMGS.TO cash_flow (annual, 2022-12-31) — End Cash Position: 408966000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -929404000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: 844015000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -7888000.00
CMGS.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 564191000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Goodwill: 21939000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 21939000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 6988136000.00
CMGS.TO income_statement (annual, 2022-12-31) — Gross Profit: 2062119000.00
CMGS.TO income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 21139000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 275796000.00
CMGS.TO income_statement (annual, 2022-12-31) — Interest Income: 21128000.00
CMGS.TO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 21128000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Inventory: 35668000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 2368023000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -830032000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Investments And Advances: 388055000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Land And Improvements: 12943000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Leases: 2317277000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 3495162000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 3495162000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 242166000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
CMGS.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -830140000.00
CMGS.TO income_statement (annual, 2022-12-31) — Net Income: 899101000.00
CMGS.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 899101000.00
CMGS.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 899101000.00
CMGS.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 899101000.00
CMGS.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 899101000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 899101000.00
CMGS.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 899101000.00
CMGS.TO income_statement (annual, 2022-12-31) — Net Interest Income: 21128000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -350868000.00
CMGS.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 21128000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -99264000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Net PPE: 5253549000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -479164000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 2346084000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 98623000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 98623000.00
CMGS.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: 1548627000.00
CMGS.TO income_statement (annual, 2022-12-31) — Normalized Income: 937682939.00
CMGS.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 1323179000.00
CMGS.TO income_statement (annual, 2022-12-31) — Operating Income: 1211102000.00
CMGS.TO income_statement (annual, 2022-12-31) — Operating Revenue: 8634652000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 1381350000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Other Current Assets: 86412000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -7888000.00
CMGS.TO income_statement (annual, 2022-12-31) — Other Gand A: 564191000.00
CMGS.TO income_statement (annual, 2022-12-31) — Other Income Expense: -50699000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: -16202000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 88124000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 43816000.00
CMGS.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: 29560000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Other Properties: 4292297000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 515136000.00
CMGS.TO income_statement (annual, 2022-12-31) — Other Special Charges: 29560000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Payables: 220133000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 502561000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 86412000.00
CMGS.TO income_statement (annual, 2022-12-31) — Pretax Income: 1181531000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Properties: 0.00
CMGS.TO cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: -760000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
CMGS.TO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -614416000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -479164000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Receivables: 154621000.00
CMGS.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 6572533000.00
CMGS.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 286826000.00
CMGS.TO income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 460425000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -830140000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: 4828248000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Sale Of Investment: 263548000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
CMGS.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 564191000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Share Issued: 1866000000.00
CMGS.TO income_statement (annual, 2022-12-31) — Special Income Charges: -50699000.00
CMGS.TO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 98030000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 2368023000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 2346084000.00
CMGS.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -12117061.00
CMGS.TO income_statement (annual, 2022-12-31) — Tax Provision: 282430000.00
CMGS.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.24
CMGS.TO balance_sheet (annual, 2022-12-31) — Taxes Receivable: 47741000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Total Assets: 6927504000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 2368023000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Total Debt: 3731410000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 2368023000.00
CMGS.TO income_statement (annual, 2022-12-31) — Total Expenses: 7423550000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 4559481000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 5751667000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 3637601000.00
CMGS.TO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 1160403000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 35567000.00
CMGS.TO income_statement (annual, 2022-12-31) — Total Unusual Items: -50699000.00
CMGS.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -50699000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 484650000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Treasury Stock: 4282014000.00
CMGS.TO balance_sheet (annual, 2022-12-31) — Working Capital: 253957000.00
CMGS.TO income_statement (annual, 2023-12-31) — +Operating Expense: 952978000.00
CMGS.TO income_statement (annual, 2023-12-31) — +Total Revenue: 9871649000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 197646000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 115535000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1982022000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1937794000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -2742000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 37025000.00
CMGS.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 4883132489.00
CMGS.TO income_statement (annual, 2023-12-31) — Basic EPS: 0.25
CMGS.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 408966000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -560731000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 4051625000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 18741000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 560609000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 1295447000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Cash Equivalents: 432151000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Cash Financial: 128458000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -660652000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -946009000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 1783477000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Change In Account Payable: 5313000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 60236000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Change In Inventory: -3649000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 258445000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -205046000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 30448000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Change In Payable: 5313000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 65549000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -39211000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Change In Receivables: -11216000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: 95320000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -11216000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Changes In Cash: 176816000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Common Stock: 18741000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 3062207000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Common Stock Payments: -592349000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Construction In Progress: 161721000.00
CMGS.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 7285557000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 272465000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Current Assets: 1620713000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 248074000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 248074000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 209680000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 209680000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 1030625000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Current Provisions: 30169000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Deferred Income Tax: -9505000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Deferred Tax: -9505000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 319394000.00
CMGS.TO income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 319394000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 319394000.00
CMGS.TO income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 319394000.00
CMGS.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 4910600663.00
CMGS.TO income_statement (annual, 2023-12-31) — Diluted EPS: 0.25
CMGS.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 1228737000.00
CMGS.TO income_statement (annual, 2023-12-31) — EBIT: 1633114000.00
CMGS.TO income_statement (annual, 2023-12-31) — EBITDA: 1952508000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 381000.00
CMGS.TO cash_flow (annual, 2023-12-31) — End Cash Position: 586163000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: -660652000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: 1222746000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -6657000.00
CMGS.TO income_statement (annual, 2023-12-31) — General And Administrative Expense: 633584000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Goodwill: 21939000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 21939000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 118277000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 7730608000.00
CMGS.TO income_statement (annual, 2023-12-31) — Gross Profit: 2586092000.00
CMGS.TO income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 38370000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 400229000.00
CMGS.TO income_statement (annual, 2023-12-31) — Interest Income: 62693000.00
CMGS.TO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 62693000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Inventory: 39309000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 3062207000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -946009000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Investments And Advances: 564488000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Land And Improvements: 12943000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Leases: 2595866000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 3803551000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 3803551000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 267294000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -592349000.00
CMGS.TO income_statement (annual, 2023-12-31) — Net Income: 1228737000.00
CMGS.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 1228737000.00
CMGS.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 1228737000.00
CMGS.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 1228737000.00
CMGS.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 1228737000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 1228737000.00
CMGS.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 1228737000.00
CMGS.TO income_statement (annual, 2023-12-31) — Net Interest Income: 62693000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -385278000.00
CMGS.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 62693000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -68303000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Net PPE: 5748586000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -560731000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 3040268000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 89109000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 89109000.00
CMGS.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: 2027809000.00
CMGS.TO income_statement (annual, 2023-12-31) — Normalized Income: 1285815158.00
CMGS.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 1783477000.00
CMGS.TO income_statement (annual, 2023-12-31) — Operating Income: 1633114000.00
CMGS.TO income_statement (annual, 2023-12-31) — Operating Revenue: 9871649000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 1371300000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Other Current Assets: 19792000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -6657000.00
CMGS.TO income_statement (annual, 2023-12-31) — Other Gand A: 633584000.00
CMGS.TO income_statement (annual, 2023-12-31) — Other Income Expense: -75301000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: -13080000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 88636000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 58870000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Other Properties: 4692784000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 734838000.00
CMGS.TO income_statement (annual, 2023-12-31) — Other Special Charges: 36931000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Payables: 239717000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 512182000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 30520000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Prepaid Assets: 97670000.00
CMGS.TO income_statement (annual, 2023-12-31) — Pretax Income: 1620506000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Properties: 0.00
CMGS.TO cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 1570000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -1115131000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -560731000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Receivables: 168495000.00
CMGS.TO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 7285557000.00
CMGS.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 319394000.00
CMGS.TO income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 503264000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -592349000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: 6056985000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Sale Of Investment: 729853000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
CMGS.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 633584000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Share Issued: 1874150000.00
CMGS.TO income_statement (annual, 2023-12-31) — Special Income Charges: -75301000.00
CMGS.TO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 124016000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 3062207000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 3040268000.00
CMGS.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -18222842.00
CMGS.TO income_statement (annual, 2023-12-31) — Tax Provision: 391769000.00
CMGS.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.24
CMGS.TO balance_sheet (annual, 2023-12-31) — Taxes Receivable: 52960000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Total Assets: 8044362000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 3062207000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Total Debt: 4051625000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 3062207000.00
CMGS.TO income_statement (annual, 2023-12-31) — Total Expenses: 8238535000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 4982155000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 6423649000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 3951530000.00
CMGS.TO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 1557813000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 42071000.00
CMGS.TO income_statement (annual, 2023-12-31) — Total Unusual Items: -75301000.00
CMGS.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -75301000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 502850000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Treasury Stock: 4944656000.00
CMGS.TO balance_sheet (annual, 2023-12-31) — Working Capital: 590088000.00
CMGS.TO balance_sheet (quarterly, 2024-09-30) — Preferred Stock: 0.00
CMGS.TO balance_sheet (quarterly, 2024-09-30) — Treasury Shares Number: 0.00
CMGS.TO balance_sheet (quarterly, 2024-09-30) — Treasury Stock: 0.00
CMGS.TO income_statement (annual, 2024-12-31) — +Operating Expense: 1032513000.00
CMGS.TO income_statement (annual, 2024-12-31) — +Total Revenue: 11313853000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 210695000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 143963000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -2249301000.00
CMGS.TO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -2249301000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 2078010000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -2953000.00
CMGS.TO balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -2953000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 24582000.00
CMGS.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 4849791442.00
CMGS.TO income_statement (quarterly, 2024-12-31) — Basic Average Shares: 4825034643.00
CMGS.TO income_statement (annual, 2024-12-31) — Basic EPS: 0.32
CMGS.TO income_statement (quarterly, 2024-12-31) — Basic EPS: 0.07
CMGS.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 586163000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -593603000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 4540618000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 13586000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 748537000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1420665000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Cash Equivalents: 652568000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Cash Financial: 95969000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -1073699000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -837526000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 2105076000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Change In Account Payable: 8467000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 62141000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Change In Inventory: -9797000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 267897000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -214636000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 31776000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Change In Payable: 8467000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 70608000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 9244000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Change In Receivables: -29274000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: 125818000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -29274000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Changes In Cash: 193851000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Common Stock: 13586000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 3655546000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Common Stock Payments: -1001559000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Construction In Progress: 192945000.00
CMGS.TO balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 192945000.00
CMGS.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 8296161000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 324808000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Current Assets: 1780587000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 277836000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 277836000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 238577000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 238577000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 1168768000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Current Provisions: 34404000.00
CMGS.TO balance_sheet (quarterly, 2024-12-31) — Current Provisions: 34404000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Deferred Income Tax: -42937000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Deferred Tax: -42937000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 335030000.00
CMGS.TO income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 335030000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 335030000.00
CMGS.TO income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 335030000.00
CMGS.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 4878897074.00
CMGS.TO income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 4851847125.00
CMGS.TO income_statement (annual, 2024-12-31) — Diluted EPS: 0.31
CMGS.TO income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.07
CMGS.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 1534110000.00
CMGS.TO income_statement (annual, 2024-12-31) — EBIT: 1985179000.00
CMGS.TO income_statement (annual, 2024-12-31) — EBITDA: 2320209000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -1635000.00
CMGS.TO cash_flow (annual, 2024-12-31) — End Cash Position: 778379000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -1073699000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: 1511473000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -10282000.00
CMGS.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 697483000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Goodwill: 21939000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 21939000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 146916000.00
CMGS.TO balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 146916000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 8639554000.00
CMGS.TO income_statement (annual, 2024-12-31) — Gross Profit: 3017692000.00
CMGS.TO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 26949000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 532862000.00
CMGS.TO income_statement (annual, 2024-12-31) — Interest Income: 93897000.00
CMGS.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 93897000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Inventory: 48942000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 3655546000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -837526000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Investments And Advances: 868025000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Land And Improvements: 12943000.00
CMGS.TO balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 12943000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Leases: 2918408000.00
CMGS.TO balance_sheet (quarterly, 2024-12-31) — Leases: 2918408000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 4262782000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 4262782000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 293841000.00
CMGS.TO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 293841000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -1001559000.00
CMGS.TO income_statement (annual, 2024-12-31) — Net Income: 1534110000.00
CMGS.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 1534110000.00
CMGS.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 1534110000.00
CMGS.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 1534110000.00
CMGS.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 1534110000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 1534110000.00
CMGS.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 1534110000.00
CMGS.TO income_statement (annual, 2024-12-31) — Net Interest Income: 93897000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -264036000.00
CMGS.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 93897000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -72140000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Net PPE: 6390253000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -573490000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 3633607000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 46208000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 46208000.00
CMGS.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: 2389055000.00
CMGS.TO income_statement (annual, 2024-12-31) — Normalized Income: 1586649926.80
CMGS.TO balance_sheet (annual, 2024-12-31) — Notes Receivable: 2250000.00
CMGS.TO balance_sheet (quarterly, 2024-12-31) — Notes Receivable: 2250000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 2105076000.00
CMGS.TO income_statement (annual, 2024-12-31) — Operating Income: 1985179000.00
CMGS.TO income_statement (annual, 2024-12-31) — Operating Revenue: 11313853000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 1358751000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Other Current Assets: 17285000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -10282000.00
CMGS.TO income_statement (annual, 2024-12-31) — Other Gand A: 697483000.00
CMGS.TO income_statement (annual, 2024-12-31) — Other Income Expense: -68846000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: -3472000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 143570000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 71070000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Other Properties: 5221417000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 672128000.00
CMGS.TO income_statement (annual, 2024-12-31) — Other Special Charges: 41897000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Payables: 257901000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 582709000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 35242000.00
CMGS.TO balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 35242000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CMGS.TO balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 0.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 80253000.00
CMGS.TO balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 80253000.00
CMGS.TO income_statement (annual, 2024-12-31) — Pretax Income: 2010230000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Properties: 0.00
CMGS.TO balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CMGS.TO cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 215000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -986673000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -593603000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Receivables: 213442000.00
CMGS.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 8296161000.00
CMGS.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 335030000.00
CMGS.TO income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 563374000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -1001559000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: 1574232000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Sale Of Investment: 722637000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Sale Of PPE: 20113000.00
CMGS.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 697483000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Share Issued: 1358751000.00
CMGS.TO income_statement (annual, 2024-12-31) — Special Income Charges: -68846000.00
CMGS.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 131730000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 3655546000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 3633607000.00
CMGS.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -16306073.20
CMGS.TO income_statement (annual, 2024-12-31) — Tax Provision: 476120000.00
CMGS.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.24
CMGS.TO balance_sheet (annual, 2024-12-31) — Taxes Receivable: 67229000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Total Assets: 9204374000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 3655546000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Total Debt: 4540618000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 3655546000.00
CMGS.TO income_statement (annual, 2024-12-31) — Total Expenses: 9328674000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 5548828000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 7423787000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 4380060000.00
CMGS.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 1916333000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 47206000.00
CMGS.TO balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 47206000.00
CMGS.TO income_statement (annual, 2024-12-31) — Total Unusual Items: -68846000.00
CMGS.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -68846000.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Treasury Stock: 0.00
CMGS.TO balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 0.00
CMGS.TO balance_sheet (annual, 2024-12-31) — Working Capital: 611819000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 259994000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 2875253000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 217406000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 101594000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 2117803000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 6018000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 4800791764.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.08
CMGS.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 778379000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -144810000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 4633079000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 13498000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 725597000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1414722000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 638001000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Cash Financial: 87596000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -585174000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 6079000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 557075000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 13208000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -107196000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: 7535000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 72601000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -54660000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 82376000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Change In Payable: 13208000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -93988000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -9748000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 43239000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 47355000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 43239000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -22020000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 13498000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 3490872000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -553796000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2121631000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 339736000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 1661648000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 284505000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 284505000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 203744000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 203744000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1091538000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -7329000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: -7329000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 87211000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 87211000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 87211000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 87211000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 4822769847.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.08
CMGS.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 386599000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — EBIT: 493628000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — EBITDA: 580839000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -236000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 756123000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -585174000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 412265000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -9847000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 172783000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Goodwill: 21939000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 21939000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 6512510000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 753622000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 6168000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 8754000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 46147000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Interest Income: 22253000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 22253000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 41387000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 3490872000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 6079000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 701056000.00